Recursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science and engineering to radically improve the lives of patients and industrialize drug discovery. 

View our most recent corporate presentation.

Recent News
Aug 16, 2021
Recursion Appoints Jordan Christensen as Vice President of Engineering

Recursion, a digital biology company industrializing drug discovery, today announced the appointment of Jordan Christensen as its Vice President of Engineering. In addition to leading all of...

Aug 13, 2021
Recursion Reports Second Quarter 2021 Financials and Provides Business Updates

Recursion (Nasdaq: RXRX), a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering,...

Jul 13, 2021
Recursion Announces Therapeutics Advisory Board, Chaired by Joseph Miletich, MD, PhD

Recursion (NASDAQ: RXRX), a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, machine learning and engineering,...

Stock Info
NASDAQRXRX